Ian Logan

Dr. Ian Logan is a Researcher at Newcastle University, specializing in molecular mechanisms related to prostate cancer and renal disease. His work focuses on androgen receptor signaling, epigenetic regulation, and ubiquitin-mediated pathways in cellular processes.

• Key collaborations with Professors Craig Robson, Neil Sheerin, and David Neal
• Extensive research in renal physiology, hypertension management, and prostate cancer therapeutics

Research trends across 15 publications (2002-2022) highlight expertise in:

• Androgen receptor interactions with histone deacetylase and SMAD3
• Mechanisms of renal fibrosis (SETD7, TGFβ signaling)
• Ubiquitin pathway modulation (MDM2, PIRH2, Usp12)
• Cancer cell apoptosis through Nutlin-3 and c-FLIP inhibition
• Sex/gender differences in disease outcomes (hypertension, COVID-19 mortality)

His work spans interdisciplinary domains including biochemistry, genetics, nephrology, and oncology, with a focus on translational implications for kidney disease and prostate cancer.